Balancing Pain Management: Patient-Centric Approach

EP: 1.Optimizing Opioid Stewardship: Unveiling Bias in Language and in Patient-Centered Care

EP: 2.Navigating Opioid Terminology: Charting and Counseling Best Practices

EP: 3.Empowering Pharmacy: Addressing Biases and Enhancing Opioid Stewardship

EP: 4.Strategies for Positive Change in Opioid Prescribing

Now Viewing

EP: 5.Balancing Pain Management: Patient-Centric Approach

EP: 6.Optimizing Pain Assessment: Tools and Risk Mitigation

EP: 7.Balancing Opioid Management Challenges for Health Care Professionals

EP: 8.Optimizing Opioid Delivery for Patient Safety

EP: 9.Optimizing Medication Efficiency with Prefilled Syringes

EP: 10.Enhancing Workflows: Cost Savings, Safety, and Collaboration

EP: 11.Compliance and Stewardship: Waste Reduction and Cost Savings

EP: 12.Insights and Strategies Into Optimizing Opioid Management

This is a video synopsis/summary of a Practice Pearls featuring Ryan Haumschild, PharmD, MS, MBA, CPEL; Megan Mitchell, PharmD, MS; Stephanie Abel, PharmD, BCPS; and Jennifer Grate, CPhT.

Haumschild emphasizes the importance of a patient-centric approach in managing pain, opioid use disorder, and opioid misuse. Mitchell addresses the challenge of balancing these aspects and highlights the need to differentiate between misuse, abuse, and the diagnosis of opioid use disorder. Mitchell emphasizes that patients with opioid use disorder still experience pain and suffering, and advocates for patient-specific risk mitigation and harm reduction strategies. Abel discusses the significance of understanding health care workers' barriers to accessing opioid use disorder treatment. She reveals that health care providers are at increased risk of drug misuse, partly due to increased access, and highlights policy barriers preventing them from receiving evidence-based treatment. Abel emphasizes the importance of addressing these barriers to ensure the well-being of health care professionals with opioid use disorder. Mitchell acknowledges the impact of policy and legislation on these challenges, setting the stage for further discussions in the next section.

This summary was AI-generated and reviewed by Pharmacy Times® editorial staff.